Adverum Biotechnologies, Inc.REDWOOD CITY, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy…
[Read More]
September 27 at 4:05 pm
September 27 at 10:28 am
Crispr Stock Jumps After Unveiling Timeline For FDA Submission Of First-Ever CRISPR Drug
Insider Monkey10 Best Small-Cap Semiconductor Stocks to Buy NowIn this article, we discuss 10 best small-cap semiconductor stocks to buy now. To skip the detailed…
[Read More]
September 27 at 10:13 am
Emergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral
Emergent BioSolutions Inc. EBS has acquired exclusive worldwide rights to Chimerix, Inc.’s CMRX smallpox oral antiviral product, Tembexa. The product is the first FDA-approved smallpox…
[Read More]
September 27 at 9:38 am
CRISPR, Vertex say FDA granted rolling review to experimental CRISPR therapy
MarketWatchLi Auto stock drops after cutting delivery outlook, as supply chain issues outweigh ‘robust’ demandShare of Li Auto Inc. dropped 1.7% in premarket trading Monday,…
[Read More]
September 27 at 8:30 am
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference
Wave Life Sciences USA, Inc.CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
[Read More]
September 27 at 8:15 am
Arthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures
5AM Venture Management, LLCEnhancing the depth of 5AM’s scientific and operational expertiseSAN FRANCISCO and BOSTON, Sept. 27, 2022 (GLOBE NEWSWIRE) — 5AM Ventures, a bicoastal…
[Read More]
September 27 at 8:11 am
5 Big Winners as Dollar Strengthens on Fed Rate Hike
U.S. stocks took a beating on Sep 26, with the S&P 500 and the Dow sliding into a bear market. The broader S&P 500 has…
[Read More]
September 27 at 8:00 am
Rocket Pharmaceuticals to Present at Chardan 6th Annual Genetic Medicines Conference
CRANBURY, N.J., September 27, 2022–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies…
[Read More]
September 27 at 7:00 am
Voyager Therapeutics to Participate in Upcoming Investor Conferences
Voyager Therapeutics, Inc.CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and…
[Read More]
September 27 at 7:00 am
AVROBIO to Present New Preclinical Data on Vector Safety at ESGCT Annual Congress
CAMBRIDGE, Mass., September 27, 2022–(BUSINESS WIRE)–AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease,…
[Read More]
September 26 at 7:30 am
Intellia Therapeutics to Present at October Healthcare Investor Conferences
Intellia Therapeutics, Inc.CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative…
[Read More]
September 24 at 9:45 am
Is This Growth Stock Undervalued?
Biotech company Bluebird Bio (NASDAQ: BLUE) is currently riding high. Despite these accomplishments, Bluebird is still a tiny company with a market cap of just…
[Read More]